Impact of Pneumococcal Urinary Antigen Testing in COVID-19 Patients: Outcomes from the San Matteo COVID-19 Registry (SMACORE)

Impact of Pneumococcal Urinary Antigen Testing in COVID-19 Patients: Outcomes from the San Matteo COVID-19 Registry (SMACORE)

Despite low rates of bacterial co-infections, most COVID-19 patients receive antibiotic therapy. We hypothesized that patients with positive pneumococcal urinary antigens (PUAs) would benefit from antibiotic therapy in terms of clinical outcomes (death, ICU admission, and length of stay). The San Ma...

Full description

Bibliographic Details
Main Authors: Pietro Valsecchi, Marta Colaneri, Valentina Zuccaro, Erika Asperges, Filippo Costanzo, Bianca Mariani, Silvia Roda, Rita Minucci, Francesco Bertuccio, Elia Fraolini, Matteo Bosio, Claudio Tirelli, Tiberio Oggionni, Angelo Corsico, Raffaele Bruno
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Personalized Medicine
Subjects:
COVID-19
SARS-CoV-2
<i>Streptococcus pneumoniae</i>
pneumococcal urinary antigen
antibiotic therapy
Online Access:https://www.mdpi.com/2075-4426/11/8/762

Internet

https://www.mdpi.com/2075-4426/11/8/762

Similar Items